Hormone replacement therapy method and its administration form

US7871994B2 · kind B2 · utility

Assignee

• Bayer Schering Pharma AG · DE

Inventor

• Hermann Kulmann · Berlin, DE

Key dates

• Filing date: Jan 8, 2002
• Grant date: Jan 18, 2011
• Expiry date: Jun 12, 2027

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Method for hormone replacement therapy, in which at least in the established postmenopause a daily unit with at least one hormonal component, namely with at least estrogen (E) and/or at least one gestagen (G) is administered permanently and continuously every day, characterized in that in at least one ingestion period preceding the permanent administration of hormone daily units is provided an ingestion pause (P), in which either no daily units or placebos or daily units with a much lower estrogen and/or gestagen content than during the permanent administration of hormone daily units in the established postmenopause and during the ingestion phase(s) of the preceding ingestion period are administered, as well as administration form for hormone therapy.